InsiderClue
Stocks · Health care · Pharmaceutical Preparations

GENMAB A/S

GMAB Clue Score79
Denmark CIK 0001434265
$37.07 +2.83% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $37.07 −11.76% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue2.37Operating income1.34Net income1.10EPS, diluted17.77Fiscal year 2018Revenue3.03 +27.9%Operating income1.38Net income1.47 +33.3%EPS, diluted23.73 +33.5%Fiscal year 2019Revenue5.37 +77.4%Operating income2.64Net income2.17 +47.1%EPS, diluted34.03 +43.4%Fiscal year 2020Revenue10.11 +88.4%Operating income6.31Net income4.76 +119.7%EPS, diluted72.21 +112.2%Fiscal year 2021Revenue8.42 −16.8%Operating income2.95Net income2.96 −37.9%EPS, diluted44.77 −38.0%Fiscal year 2022Revenue14.51 +72.3%Operating income6.27Net income5.45 +84.4%EPS, diluted82.59 +84.5%Fiscal year 2023Revenue16.47 +13.6%Operating income5.32Net income4.35 −20.2%EPS, diluted66.02 −20.1%Fiscal year 2024Revenue21.53 +30.7%Operating income6.70Net income7.84 +80.2%EPS, diluted121.36 +83.8%Fiscal year 2025
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.37 3.03 5.37 10.11 8.42 14.51 16.47 21.53 n/a
Growth +27.9% +77.4% +88.4% −16.8% +72.3% +13.6% +30.7%
Operating income 1.34 1.38 2.64 6.31 2.95 6.27 5.32 6.70 n/a
Net income 1.10 1.47 2.17 4.76 2.96 5.45 4.35 7.84 n/a
Growth +33.3% +47.1% +119.7% −37.9% +84.4% −20.2% +80.2%
EPS, diluted 17.77 23.73 34.03 72.21 44.77 82.59 66.02 121.36 n/a
Growth +33.5% +43.4% +112.2% −38.0% +84.5% −20.1% +83.8%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin56.8%Net margin46.7%Free cash flow margin63.4%Fiscal year 2018Operating margin45.6%Net margin48.7%Free cash flow margin31.2%Fiscal year 2019Operating margin49.2%Net margin40.4%Free cash flow margin23.2%Fiscal year 2020Operating margin62.4%Net margin47.1%Free cash flow margin60.6%Fiscal year 2021Operating margin35.1%Net margin35.1%Free cash flow margin23.5%Fiscal year 2022Operating margin43.2%Net margin37.6%Free cash flow margin24.8%Fiscal year 2023Operating margin32.3%Net margin26.4%Free cash flow margin42.6%Fiscal year 2024Operating margin31.1%Net margin36.4%Free cash flow margin35.2%Fiscal year 2025
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 56.8% 45.6% 49.2% 62.4% 35.1% 43.2% 32.3% 31.1% n/a
Net margin 46.7% 48.7% 40.4% 47.1% 35.1% 37.6% 26.4% 36.4% n/a
Free cash flow margin 63.4% 31.2% 23.2% 60.6% 23.5% 24.8% 42.6% 35.2% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow1.59Capital expenditure−0.09Free cash flow1.50Fiscal year 2018Operating cash flow1.02Capital expenditure−0.07Free cash flow0.94 −37.1%Fiscal year 2019Operating cash flow1.33Capital expenditure−0.08Free cash flow1.25 +32.2%Fiscal year 2020Operating cash flow6.43Capital expenditure−0.31Free cash flow6.13 +391.3%Fiscal year 2021Operating cash flow2.23Capital expenditure−0.25Free cash flow1.98 −67.7%Fiscal year 2022Operating cash flow3.91Capital expenditure−0.32Free cash flow3.60 +81.9%Fiscal year 2023Operating cash flow7.38Capital expenditure−0.37Free cash flow7.01 +95.1%Fiscal year 2024Operating cash flow7.77Capital expenditure−0.19Free cash flow7.58 +8.1%Fiscal year 2025
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 1.59 1.02 1.33 6.43 2.23 3.91 7.38 7.77 n/a
Capital expenditure −0.09 −0.07 −0.08 −0.31 −0.25 −0.32 −0.37 −0.19 n/a
Free cash flow 1.50 0.94 1.25 6.13 1.98 3.60 7.01 7.58 n/a
Growth −37.1% +32.2% +391.3% −67.7% +81.9% +95.1% +8.1%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash1.35Shareholders’ equity6.27Fiscal year 2018Cash0.53Shareholders’ equity8.01Fiscal year 2019Cash3.55Shareholders’ equity14.05Fiscal year 2020Cash7.26Shareholders’ equity19.12Fiscal year 2021Cash8.96Shareholders’ equity22.11Fiscal year 2022Cash9.89Shareholders’ equity27.28Fiscal year 2023Cash14.87Total debt0.00Net cash (debt)14.87Shareholders’ equity31.61Debt to equity0.00Fiscal year 2024Cash9.86Total debt0.00Net cash (debt)9.86Shareholders’ equity36.70Debt to equity0.00Fiscal year 2025Total debt5.00
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.35 0.53 3.55 7.26 8.96 9.89 14.87 9.86 n/a
Total debt n/a n/a n/a n/a n/a n/a 0.00 0.00 5.00
Net cash (debt) n/a n/a n/a n/a n/a n/a 14.87 9.86 n/a
Shareholders’ equity 6.27 8.01 14.05 19.12 22.11 27.28 31.61 36.70 n/a
Debt to equity n/a n/a n/a n/a n/a n/a 0.00 0.00 n/a

In billions of DKK, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In billions of DKK, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
1.59 1.02 1.33 6.43 2.23 3.91 7.38 7.77 n/a
Growth −36.1% +30.6% +385.1% −65.4% +75.6% +88.7% +5.3%
0.01 0.03 0.04 0.08 0.11 n/a n/a n/a n/a
Investment
−0.09 −0.07 −0.08 −0.31 −0.25 −0.32 −0.37 −0.19 n/a
calc 1.50 0.94 1.25 6.13 1.98 3.60 7.01 7.58 n/a
Growth −37.1% +32.2% +391.3% −67.7% +81.9% +95.1% +8.1%
calc 24.16 15.20 19.60 92.98 29.92 54.46 106.44 117.30 n/a
−0.67 −1.78 −1.98 −2.35 −0.96 −2.76 −1.28 −9.91 n/a
Financing
0.22 −0.07 3.66 0.07 −0.42 −0.79 −0.61 −3.92 n/a

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative. Shown in DKK as filed; the screener converts to dollars.